ArticleAnnals of the rheumatic diseases2022

High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab.

Edoardo Conticini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.